About the Chikungunya Session
The Chikungunya virus is the infection that causes chikungunya (CHIKV). Fever and joint ache are symptoms. Usually, they develop two to twelve days following exposure. A rash, headache, muscular soreness, and joint swelling are possible additional symptoms. Though symptoms often subside after a week, joint discomfort can occasionally last for months or even years. There is a one in 1,000 chance of dying. More severe illness is more likely to affect the very young, the elderly, and people with underlying health issues. Aedes albopictus and Aedes aegypti are two species of mosquitoes that transmit the virus from one person to another. They typically bite during the day. Several species, including birds and rodents, may carry the virus. Blood tests for the virus's RNA or antiviral antibodies are used to make the diagnosis. The signs and symptoms might be confused with Zika and dengue illness. After just one illness, most people supposedly develop immunity. Overall mosquito control and avoiding bites in regions where the illness is prevalent are the best methods of prevention. Insect repellent and mosquito net use, as well as reducing mosquitoes' access to water, may help to some extent. As of 2016, there is no vaccination and no particular therapy. Rest, fluids, and medications to treat fever and joint pain are all advised.
Topics Covered in Chikungunya
Chikungunya virus transmission and Aedes vectors
Acute fever, rash and joint symptoms
Chronic arthralgia and post-viral outcomes
Laboratory diagnosis and differentiation from dengue
Mosquito control and bite prevention
Outbreak surveillance in endemic regions
Featured Speakers — Chikungunya 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Chikungunya Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Chikungunya Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Chikungunya work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Chikungunya research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Chikungunya track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Chikungunya Conference 2027 — FAQs
What is the Chikungunya track at IPHC 2027?
The Chikungunya track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Chikungunya. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Chikungunya sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Chikungunya are all welcome — whether presenting or attending.
Can I present my research in the Chikungunya track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Chikungunya sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Chikungunya track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
